Is TransMedics Group Stock a Buy?
TransMedics is reaffirming its full-year guidance for revenue growth between 76% and 84% compared to 2023. According to ...
Down 80% From Its All-Time High, Is Super Micro Computer Stock a Buy?
The stock is now down more than 25% for the year and more than 80% from its all-time high, set earlier this year. With that kind of decline, some investors may wonder if it's a stock with some value ...
TD Cowen Reaffirms Their Buy Rating on Shattuck Labs (STTK)
TD Cowen analyst Marc Frahm maintained a Buy rating on Shattuck Labs (STTK – Research Report) yesterday. The company’s shares ...
Milestone Pharmaceuticals’ CARDAMYST: A Promising Buy with FDA Decision and Phase 3 Trial on Horizon
In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Milestone Pharmaceuticals (MIST – Research ...
Investors Chronicle20h
Time to cash in on this housebuilder
The developer has a lot going for it, but the market has cottoned on and the share price may have reached the end of the road ...